NCT07900841

FUS Neuromodulation for PTSD

StatusNot Yet Recruiting

PhaseNot applicable

Primary completionDec 30, 2028 (estimated)

Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 1 version: 1 with changes below.

Occurrence of Treatment Emergent Adverse Events

Timeframe: Week 4 and 12 compared to baseline

Change in PTSD Symptoms

Change in Depression

Change in anxiety

Suicidal behavior

TreatmentExperimental

FUS Neuromodulation

Devices: Focused Ultrasound

1 site in 1 country

The purpose of this study is to see if a focused ultrasound neuromodulation can be safely and effectively used to treat symptoms of PTSD

Enrollment: 15 participants (estimated)
Started: Nov 25, 2026
Study completion: Dec 30, 2029 (estimated)
Eligibility: 20 to 65, all sexes, no healthy volunteers
Design: Interventional, open label, treatment
Oversight: Data monitoring committee, FDA-regulated device
Conditions: Combat Disorders, Post Traumatic Stress Disorder PTSD
Official title: A Prospective Early Feasibility Study of Focused Ultrasound Neuromodulation for PTSD
First posted: Oct 28, 2026
Registry updated: Oct 28, 2026
Last verified: Oct 2026

View on ClinicalTrials.gov ↗